Significant Pharmaceuticals Reported in US Patents

Significant Pharmaceuticals Reported in US Patents, 1st Edition

Significant Pharmaceuticals Reported in US Patents, 1st Edition,Thomas F. DeRosa,ISBN9780080453446


Elsevier Science




240 X 165

A practical guide providing useful analytical and biological data on next generation pharmaceuticals

Print Book + eBook

USD 285.00
USD 475.00

Buy both together and save 40%

Print Book


In Stock

Estimated Delivery Time
USD 245.00

eBook Overview

VST (VitalSource Bookshelf) format

DRM-free included formats : PDF

USD 230.00
Add to Cart

Key Features

* Identifies next generation pharmaceuticals
* Provides practical preparation methods for each active agent and derivatives
* Documents the analytical characterization and biological testing results of active agents


This book identifies the next generation of pharmaceuticals reported in US Patents. This "hands-on" title provides explicit laboratory methods for preparing the most recent and effective medications. Each entry documents the biological testing protocols used to evaluate a drug and the significance of the current treatment agent over previous methods. Pharmaceuticals are included in this review only if at least two of the following criteria were met: Effectiveness in treating an illness, Innovative, ease of preparation, synergy with existing Medications.
Pharmaceuticals are reported for 27 separate classes of illness, including;
AIDS, Alzheimer's Disease, Cardiovascular Disorders, Diabetes, Epilepsy, Hepatitis C, Osteoporosis, Obesity and Sleep Disorders.
Significant Pharmaceuticals Reported in US Patents has been designed to be used as both a reference and synthetic guide for pharmaceutical, medicinal and organic chemists and graduate students.
Researchers working in other areas will also find the information valuable as in many instances intermediates or the next generation pharmaceutical are readily convertible into other industrial products including: anti-oxidants, chemical additives, herbicides, polymer precursors, water purification agents. Clear structural depictions of reagents and chemical transformations have been supplied to permit the identification of other future applications.


For academic, government, and industrial researchers interested in organic chemistry, medicinal chemistry, natural products, pharmaceuticals, pharmacology and structure-property relationships.

Thomas F. DeRosa

Affiliations and Expertise

Southbury, Connecticut, USA

View additional works by Thomas F. DeRosa

Significant Pharmaceuticals Reported in US Patents, 1st Edition

Acquired Immune Deficiency Syndrome

Addiction Disorders

Alzheimer's Disease


Antibacterial Agents

Anti-inflammatory Agents

Autoimmune Disorders

Cardiovascular Disorders




Gastrointestional Disorders

Hepatitis C

Hormonal Disorders


Improved Synthetic Methods


Irritable Bowel Syndrome



Migraine Headaches


Proliferative Disorders

Skin Disorders

Sleep Disorders

Thyroid Disorders

Free Shipping
Shop with Confidence

Free Shipping around the world
▪ Broad range of products
▪ 30 days return policy

Contact Us